首页> 外文期刊>Nature clinical practice. Oncology >The CCR9-CCL25 axis mediates melanoma metastasis to the small intestine.
【24h】

The CCR9-CCL25 axis mediates melanoma metastasis to the small intestine.

机译:CCR9-CCL25轴介导黑色素瘤转移至小肠。

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundHuman cutaneous melanoma preferentially metastasizes to the small intestine for reasons that are unclear. Previous studies have shown that thymus-expressed cytokine (CCL25) mediates chemotaxis of CCR9 lymphocytes to the small intestine. Integrin alpha and beta are known to have a role in cellular adhesion, which is an important component of metastasis.ObjectiveTo determine the mechanism of lymphocyte trafficking and tumor cell metastasis in melanoma cells that metastasize to the small intestine.Design and interventionThis study included tumor specimens from patients who had undergone surgical resection for metastatic melanoma at either the John Wayne Cancer Institute or the Sydney Cancer Center between 1996 and 2005. Paraffin-embedded archival tissue from tumor specimens were obtained for primary melanomas (n=23), distant metastases (n = 198) and small intestinal metastases (n = 23). Quantitative reverse-transcription-PCR assays, flow cytometryand immunohistochemistry were usedto assess CCR9 and CCL25 expression in the specimens. Flow cytometry was used to assess expression of integrin alpha and beta.Outcome measuresExpression of CCR9, CCL25 and integrin a and (3 were the main outcome measures.ResultsIn total, 88 of 102 paraffin-em bedded specimens of small intestinal melanoma metastases expressed CCR9, as did all 8 melanoma cell lines derived from small intestinal metastases. There was no CCR9 expression in specimens derived from melanoma patients who had undergone surgical resection for isolated metastases to other organs. CCL25 expression was upregulatedin small intestinal melanoma metastases, and in vitro migration and invasion studies showed migration of CCR9-positive melanoma cells in response to CCL25. This response was inhibited by anti-CCR9 antibody and by CCR9 short interfering RNA. Flow cytometry analysis verified CCR9 expression in small intestinal melanoma metastases and showed associated alpha and beta integrin expression.ConclusionThis study shows that CCL25 initiates the migrationand invasion of CCR9-expressing melanoma cells, which results in preferential metastasis to the small intestine, thus, validating the role of the CCR9-CCL25 axis in metastasis of cutaneous melanoma to this specific location.
机译:背景人类皮肤黑色素瘤由于不清楚的原因优先转移至小肠。先前的研究表明,胸腺表达的细胞因子(CCL25)介导CCR9淋巴细胞对小肠的趋化性。整联蛋白α和β在细胞粘附中起着重要作用,这是转移的重要组成部分。目的确定转移到小肠的黑素瘤细胞中淋巴细胞运输和肿瘤细胞转移的机制。设计和干预该研究包括肿瘤标本从1996年至2005年间在约翰韦恩癌症研究所或悉尼癌症中心接受过手术切除的转移性黑色素瘤患者中。从肿瘤标本中石蜡包埋的档案组织中获得了原发性黑色素瘤(n = 23),远处转移(n = 198)和小肠转移(n = 23)。采用定量逆转录-PCR,流式细胞术和免疫组化方法评估标本中CCR9和CCL25的表达。流式细胞术评估整联蛋白α和β的表达。结果检测CCR9,CCL25和整联蛋白a和(3个是主要的结局指标)。结果在102例石蜡包埋的小肠黑色素瘤转移标本中,有88例表达了CCR9,就像所有8种源自小肠转移瘤的黑色素瘤细胞系一样,在接受手术切除并转移到其他器官的黑色素瘤患者的标本中没有CCR9表达,CCL25表达在小肠黑色素瘤转移以及体外迁移和入侵研究表明,CCR9阳性黑色素瘤细胞迁移响应CCL25,该反应被抗CCR9抗体和CCR9短干扰RNA抑制,流式细胞仪分析证实了CCR9在小肠黑色素瘤转移中的表达,并显示了相关的α和β整合素表达结论本研究表明CCL25引发了CCL25的迁移和侵袭。表达CCR9的黑色素瘤细胞导致向小肠的优先转移,因此验证了CCR9-CCL25轴在皮肤黑色素瘤转移至此特定位置中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号